Annette Duck explains how Action for Pulmonary Fibrosis can support patients and their familes to live with a devastating lung disease. Idiopathic pulmonary fibrosis (IPF) is a terminal lung condition affecting around 15,000 people in the UK. 

The mean life expectancy for this devastating lung disease is three years, meaning that 5,000 people with IPF will die in the UK each year (Navaratnam et al, 2011).